Domperidone – No Longer Authorised for use in Children <12yrs
Following a European review of new evidence showing a lack of efficacy for domperidone for nausea & vomiting in children, the MHRA have updated UK product information and have provided the following advice for healthcare professionals: Change of indication domperidone is now authorised for the relief of symptoms of nausea and vomiting only in adults and adolescents 12 Continue Reading »
Drug Safety Update January 2020 – Reporting supected adverse events linked to e-cigarettes
The January 2020 edition of Drug Safety Update includes a reminder to be vigilant for any suspected adverse reactions associated with use of e-cigarettes or vaping (including lung injury) and report them to the MHRA via the Yellow Card Scheme. The article includes a UK case definition of e-cigarette or vaping associated lung injury to facilitate identification.
Medicines Support – HEE Training for Non-Registered Workforce
Health Education England have launched a set of training resources for the non-registered medicines workforce. To help people achieve essential skills, HEE have worked with health and social care colleagues and local Excellence Centres to develop a collection of medicines related training resources for non-registered staff across the wider workforce. These include: Medicines Administration e-Learning Modules for care Continue Reading »
DHSC Medicine Supply and Shortage Updates – January 2020
The January 2020 edition of the Supply issues update for primary and secondary care from the Department of Health & Social Care is available – along with recent letters, memos & Medicine Supply Notifications – from the NHS Specialist Pharmacy Service (SPS) [NB: Log-in before using links – Register here]. The January Supply issues update (also available from Continue Reading »
Self-Care and OTC Product Guidance for Healthcare Professionals
A detailed guide for professional use has been developed as part of the regional self-care campaign. This explains the rationale for why certain conditions may be suitable for self-care whilst highlighting any specific patient groups which may be excluded due to age or the chronic nature of their illness.
The document is to serve as a guideline for prescribers but does not remove the clinician’s right to decide the most appropriate treatment for a patient.